Problem

Spanish response to Covid poverty was too little, too late, report says Human Rights Watch says pandemic exacerbated weaknesses in country’s social security system the Guardian

...

How common is long COVID? Why studies give different answers Nature - Enormous databases do not necessarily allow scientists to solve long COVID mysteries, such as how well vaccination protects against the condition. Ledford, Heidi nature

Clinical epidemiologist Ziyad Al-Aly has access to a treasure trove that many researchers can only dream of: millions of sets of electronic medical records from the US Department of Veterans Affairs (VA), which provides health care for the country’s military veterans.

Paxlovid Misses in Standard-Risk COVID-19 Trend toward advantage in secondary endpoint of hospitalization or death, but not significant Kristina Fiore medpagetoday

Updated findings from a nirmatrelvir/ritonavir (Paxlovid) trial in standard-risk COVID-19 suggest the antiviral's benefits are less clear for those not at high risk of severe outcomes.